Generic Medicine Market by Product Type, Application, Distribution Channel - Global Industry Analysis & Forecast to 2027
Published On : April 2020 Pages : 170 Category: Pharma & Healthcare Report Code : HC0410285
Generic Medicine Market by Product Type (Simple Generics, Super Generics, and Biosimilars); by Application (Cardiovascular Products, Anti-Infective Drugs, Anti-Arthritis Drugs, Central Nervous System Drugs, Anti-Cancer Drugs, and Respiratory Products), Distribution Channel (Hospitals, Pharmacies, Private Clinics, Drug Stores, and Retail Pharmacies - Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Generic Medicine Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Generic drugs are duplicates of brand-name drugs that have exactly the same dosage, intended use, effects, side effects, route of administration, risks, safety, and strength as the original drug. In other words, their pharmacological effects are exactly the same as those of their brand-name counterparts.
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
-
- Abbott laboratories
- Teva pharmaceutical industries ltd.
- Allergan plc
- Sandoz international gmbh
- Mylan n.v.
- Stada arzneimittel ag
- Baxter international inc.
- Eli lilly and company
- Glaxosmithkline plc
- Pfizer inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Generic Medicine Market, By Product Type, Estimates and Forecast, 2017-2027 ($Million)
o Simple Generics
o Super Generics
o Biosimilars
· Generic Medicine Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Cardiovascular Products
o Anti-Infective Drugs
o Anti-Arthritis Drugs
o Central Nervous System Drugs
o Anti-Cancer Drugs
o Respiratory Products
· Generic Medicine Market, By Distribution Channel, Estimates and Forecast, 2017-2027 ($Million)
o Hospitals
o Pharmacies
o Private Clinics
o Drug Stores
o Retail Pharmacies
· Generic Medicine Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Abbott laboratories
o Teva pharmaceutical industries ltd.
o Allergan plc
o Sandoz international gmbh
o Mylan n.v.
o Stada arzneimittel ag
o Baxter international inc.
o Eli lilly and company
o Glaxosmithkline plc
o Pfizer inc.
· Generic Medicine Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Submarine Cables Market, By Country
o U.S. Submarine Cables Market
o Canada Submarine Cables Market
o Mexico Submarine Cables Market
o Europe
§ Europe Submarine Cables Market, By Country
o Germany Submarine Cables Market
o UK Submarine Cables Market
o France Submarine Cables Market
o Russia Submarine Cables Market
o Italy Submarine Cables Market
o Rest of Europe Submarine Cables Market
o Asia-Pacific
§ Asia-Pacific Submarine Cables Market, By Country
o China Submarine Cables Market
o Japan Submarine Cables Market
o South Korea Submarine Cables Market
o India Submarine Cables Market
o Southeast Asia Submarine Cables Market
o Rest of Asia-Pacific Submarine Cables Market
o South America
§ South America Submarine Cables Market
o Brazil Submarine Cables Market
o Argentina Submarine Cables Market
o Columbia Submarine Cables Market
o Rest of South America Submarine Cables Market
o Middle East and Africa
§ Middle East and Africa Submarine Cables Market
o Saudi Arabia Submarine Cables Market
o UAE Submarine Cables Market
o Egypt Submarine Cables Market
o Nigeria Submarine Cables Market
o South Africa Submarine Cables Market
o Rest of MEA Submarine Cables Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Generic Medicine Market, By Product Type
5.1. Introduction
5.2. Global Generic Medicine Revenue and Market Share by Product Type (2017-2021)
5.2.1. Global Generic Medicine Revenue and Revenue Share by Product Type (2017-2021)
5.3. Simple Generics
5.3.1. Global Simple Generics Revenue and Growth Rate (2017-2021)
5.4. Super Generics
5.4.1. Global Super Generics Revenue and Growth Rate (2017-2021)
5.5. Biosimilars
5.5.1. Global Biosimilars Revenue and Growth Rate (2017-2021)
6. Generic Medicine Market, By Applications
6.1. Introduction
6.2. Global Generic Medicine Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Generic Medicine Revenue and Revenue Share by Applications (2017-2021)
6.3. Cardiovascular Products
6.3.1. Global Cardiovascular Products Revenue and Growth Rate (2017-2021)
6.4. Anti-Infective Drugs
6.4.1. Global Anti-Infective Drugs Revenue and Growth Rate (2017-2021)
6.5. Anti-Arthritis Drugs
6.5.1. Global Anti-Arthritis Drugs Revenue and Growth Rate (2017-2021)
6.6. Central Nervous System Drugs
6.6.1. Global Central Nervous System Drugs Revenue and Growth Rate (2017-2021)
6.7. Anti-Cancer Drugs
6.7.1. Global Anti-Cancer Drugs Revenue and Growth Rate (2017-2021)
6.8. Respiratory Products
6.8.1. Global Respiratory Products Revenue and Growth Rate (2017-2021)
6.9. Others
6.9.1. Global Others Revenue and Growth Rate (2017-2021)
7. Generic Medicine Market, By Distribution Channel
7.1. Introduction
7.2. Global Generic Medicine Revenue and Market Share by Distribution Channel (2017-2021)
7.2.1. Global Generic Medicine Revenue and Revenue Share by Distribution Channel (2017-2021)
7.3. Hospitals
7.3.1. Global Hospitals Revenue and Growth Rate (2017-2021)
7.4. Pharmacies
7.4.1. Global Pharmacies Revenue and Growth Rate (2017-2021)
7.5. Private Clinics
7.5.1. Global Private Clinics Revenue and Growth Rate (2017-2021)
7.6. Drug Stores
7.6.1. Global Drug Stores Revenue and Growth Rate (2017-2021)
7.7. Retail Pharmacies
7.7.1. Global Retail Pharmacies Revenue and Growth Rate (2017-2021)
8. Generic Medicine Market, By Region
8.1. Introduction
8.2. Global Generic Medicine Revenue and Market Share by Regions
8.2.1. Global Generic Medicine Revenue by Regions (2017-2021)
8.3. North America Generic Medicine by Countries
8.3.1. North America Generic Medicine Revenue and Growth Rate (2017-2021)
8.3.2. North America Generic Medicine Revenue (Million USD) by Countries (2017-2021)
8.3.3. United States
8.3.3.1. United States Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.3.4. Canada
8.3.4.1. Canada Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.3.5. Mexico
8.3.5.1. Mexico Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.4. Europe Generic Medicine by Countries
8.4.1. Europe Generic Medicine Revenue and Growth Rate (2017-2021)
8.4.2. Europe Generic Medicine Revenue (Million USD) by Countries (2017-2021)
8.4.3. Germany
8.4.3.1. Germany Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.4. France
8.4.4.1. France Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.5. UK
8.4.5.1. UK Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.6. Russia
8.4.6.1. Russia Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.7. Italy
8.4.7.1. Italy Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.5. Asia-Pacific Generic Medicine by Countries
8.5.1. Asia-Pacific Generic Medicine Revenue and Growth Rate (2017-2021)
8.5.2. Asia-Pacific Generic Medicine Revenue (Million USD) by Countries (2017-2021)
8.5.3. China
8.5.3.1. China Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.4. Japan
8.5.4.1. Japan Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.5. Korea
8.5.5.1. Korea Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.6. India
8.5.6.1. India Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.6. South America Generic Medicine by Countries
8.6.1. South America Generic Medicine Revenue and Growth Rate (2017-2021)
8.6.2. South America Generic Medicine Revenue (Million USD) by Countries (2017-2021)
8.6.3. Brazil
8.6.3.1. Brazil Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.4. Argentina
8.6.4.1. Argentina Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.5. Columbia
8.6.5.1. Columbia Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7. Middle East and Africa Generic Medicine by Countries
8.7.1. Middle East and Africa Generic Medicine Revenue and Growth Rate (2017-2021)
8.7.2. Middle East and Africa Generic Medicine Revenue (Million USD) by Countries (2017-2021)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.5. Egypt
8.7.5.1. Egypt Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.6. Nigeria
8.7.6.1. Nigeria Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.7. South Africa
8.7.7.1. South Africa Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.8. Turkey
8.7.8.1. Turkey Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2021)
9. Company Profiles
9.1. Abbott laboratories
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. Teva pharmaceutical industries ltd.
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Allergan plc
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Sandoz international gmbh
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Mylan n.v.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. Stada arzneimittel ag
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Baxter international inc.
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Eli lilly and company
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Glaxosmithkline plc
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Pfizer inc.
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
10. Generic Medicine Market Forecast (2022-2027)
10.1. Global Generic Medicine Revenue (Millions USD) and Growth Rate (2022-2027)
10.2. Generic Medicine Market Forecast by Regions (2022-2027)
10.2.1. North America Generic Medicine Market Forecast (2022-2027)
10.2.1.1. United States Generic Medicine Market Forecast (2022-2027)
10.2.1.2. Canada Generic Medicine Market Forecast (2022-2027)
10.2.1.3. Mexico Generic Medicine Market Forecast (2022-2027)
10.2.2. Europe Generic Medicine Market Forecast (2022-2027)
10.2.2.1. Germany Generic Medicine Market Forecast (2022-2027)
10.2.2.2. France Generic Medicine Market Forecast (2022-2027)
10.2.2.3. UK Generic Medicine Market Forecast (2022-2027)
10.2.2.4. Russia Generic Medicine Market Forecast (2022-2027)
10.2.2.5. Italy Generic Medicine Market Forecast (2022-2027)
10.2.2.6. Rest of Europe Generic Medicine Market Forecast (2022-2027)
10.2.3. Asia-Pacific Generic Medicine Market Forecast (2022-2027)
10.2.3.1. China Generic Medicine Market Forecast (2022-2027)
10.2.3.2. Japan Generic Medicine Market Forecast (2022-2027)
10.2.3.3. Korea Generic Medicine Market Forecast (2022-2027)
10.2.3.4. India Generic Medicine Market Forecast (2022-2027)
10.2.3.5. Southeast Asia Generic Medicine Market Forecast (2022-2027)
10.2.3.6. Rest of Asia-Pacific Generic Medicine Market Forecast (2022-2027)
10.2.4. South America Generic Medicine Market Forecast (2022-2027)
10.2.4.1. Brazil Generic Medicine Market Forecast (2022-2027)
10.2.4.2. Argentina Generic Medicine Market Forecast (2022-2027)
10.2.4.3. Columbia Generic Medicine Market Forecast (2022-2027)
10.2.4.4. Rest of South America Generic Medicine Market Forecast (2022-2027)
10.2.5. Middle East and Africa Generic Medicine Market Forecast (2022-2027)
10.2.5.1. Saudi Arabia Generic Medicine Market Forecast (2022-2027)
10.2.5.2. United Arab Emirates Generic Medicine Market Forecast (2022-2027)
10.2.5.3. Egypt Generic Medicine Market Forecast (2022-2027)
10.2.5.4. Nigeria Generic Medicine Market Forecast (2022-2027)
10.2.5.5. South Africa Generic Medicine Market Forecast (2022-2027)
10.2.5.6. Turkey Generic Medicine Market Forecast (2022-2027)
10.2.5.7. Rest of Middle East and Africa Generic Medicine Market Forecast (2022-2027)
10.3. Generic Medicine Market Forecast by Product Type (2022-2027)
10.3.1. Generic Medicine Forecast by Product Type (2022-2027)
10.3.2. Generic Medicine Market Share Forecast by Product Type (2022-2027)
10.4. Generic Medicine Market Forecast by Applications (2022-2027)
10.4.1. Generic Medicine Forecast by Applications (2022-2027)
10.4.2. Generic Medicine Market Share Forecast by Applications (2022-2027)
10.5. Generic Medicine Market Forecast by Distribution Channel (2022-2027)
10.5.1. Generic Medicine Forecast by Distribution Channel (2022-2027)
10.5.2. Generic Medicine Market Share Forecast by Distribution Channel (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Generic Medicine Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Generic Medicine Revenue and Revenue Share by Product Type (2017-2019)
Figure Global Simple Generics Revenue and Growth Rate (2017-2019)
Figure Global Super Generics Revenue and Growth Rate (2017-2019)
Figure Global Biosimilars Revenue and Growth Rate (2017-2019)
Table Global Generic Medicine Revenue and Revenue Share by Applications (2017-2019)
Figure Global Cardiovascular Products Revenue and Growth Rate (2017-2019)
Figure Global Anti-Infective Drugs Revenue and Growth Rate (2017-2019)
Figure Global Anti-Arthritis Drugs Revenue and Growth Rate (2017-2019)
Figure Global Central Nervous System Drugs Revenue and Growth Rate (2017-2019)
Figure Global Anti-Cancer Drugs Revenue and Growth Rate (2017-2019)
Figure Global Respiratory Products Revenue and Growth Rate (2017-2019)
Figure Global Others Revenue and Growth Rate (2017-2019)
Table Global Generic Medicine Revenue and Revenue Share by Distribution Channel (2017-2019)
Figure Global Hospitals Revenue and Growth Rate (2017-2019)
Figure Global Pharmacies Revenue and Growth Rate (2017-2019)
Figure Global Private Clinics Revenue and Growth Rate (2017-2019)
Figure Global Drug Stores Revenue and Growth Rate (2017-2019)
Figure Global Retail Pharmacies Revenue and Growth Rate (2017-2019)
Table Global Generic Medicine Revenue by Regions (2017-2019)
Figure North America Generic Medicine Growth Rate (2017-2019)
Figure North America Generic Medicine Revenue and Growth Rate (2017-2019)
Figure North America Generic Medicine by Countries (2017-2019)
Figure North America Generic Medicine Revenue (Million USD) by Countries (2017-2019)
Figure United States Generic Medicine Growth Rate (2017-2019)
Figure United States Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Generic Medicine Growth Rate (2017-2019)
Figure Canada Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Generic Medicine Growth Rate (2017-2019)
Figure Mexico Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Generic Medicine Growth Rate (2017-2019)
Figure Europe Generic Medicine Revenue and Growth Rate (2017-2019)
Figure Europe Generic Medicine by Countries (2017-2019)
Figure Europe Generic Medicine Revenue (Million USD) by Countries (2017-2019)
Figure Germany Generic Medicine Growth Rate (2017-2019)
Figure Germany Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Generic Medicine Growth Rate (2017-2019)
Figure France Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Generic Medicine Growth Rate (2017-2019)
Figure UK Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Generic Medicine Growth Rate (2017-2019)
Figure Russia Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Generic Medicine Growth Rate (2017-2019)
Figure Italy Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Generic Medicine Growth Rate (2017-2019)
Figure Rest of Europe Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Generic Medicine Growth Rate (2017-2019)
Figure Asia-Pacific Generic Medicine Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Generic Medicine by Countries (2017-2019)
Figure Asia-Pacific Generic Medicine Revenue (Million USD) by Countries (2017-2019)
Figure China Generic Medicine Growth Rate (2017-2019)
Figure China Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Generic Medicine Growth Rate (2017-2019)
Figure Japan Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Generic Medicine Growth Rate (2017-2019)
Figure Korea Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Generic Medicine Growth Rate (2017-2019)
Figure India Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Generic Medicine Growth Rate (2017-2019)
Figure Southeast Asia Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Generic Medicine Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Generic Medicine Growth Rate (2017-2019)
Figure South America Generic Medicine Revenue and Growth Rate (2017-2019)
Figure South America Generic Medicine by Countries (2017-2019)
Figure South America Generic Medicine Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Generic Medicine Growth Rate (2017-2019)
Figure Brazil Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Generic Medicine Growth Rate (2017-2019)
Figure Argentina Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Generic Medicine Growth Rate (2017-2019)
Figure Columbia Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Generic Medicine Growth Rate (2017-2019)
Figure Rest of South America Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Generic Medicine Growth Rate (2017-2019)
Figure Middle East and Africa Generic Medicine Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Generic Medicine by Countries (2017-2019)
Figure Middle East and Africa Generic Medicine Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Generic Medicine Growth Rate (2017-2019)
Figure Saudi Arabia Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Generic Medicine Growth Rate (2017-2019)
Figure United Arab Emirates Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Generic Medicine Growth Rate (2017-2019)
Figure Egypt Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Generic Medicine Growth Rate (2017-2019)
Figure Nigeria Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Generic Medicine Growth Rate (2017-2019)
Figure South Africa Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Generic Medicine Growth Rate (2017-2019)
Figure Turkey Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Generic Medicine Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Generic Medicine Revenue (Millions USD) and Growth Rate (2017-2019)
Table Abbott laboratories Generic Medicine Financial Overview
Table Teva pharmaceutical industries ltd. Generic Medicine Financial Overview
Table Allergan plc Generic Medicine Financial Overview
Table Sandoz international gmbh Generic Medicine Financial Overview
Table Mylan n.v. Generic Medicine Financial Overview
Table Stada arzneimittel ag Generic Medicine Financial Overview
Table Baxter international inc. Generic Medicine Financial Overview
Table Eli lilly and company Generic Medicine Financial Overview
Table Glaxosmithkline plc Generic Medicine Financial Overview
Table Pfizer inc. Generic Medicine Financial Overview
Figure Global Generic Medicine Revenue (Millions USD) and Growth Rate (2019-2027)
Table Generic Medicine Market Forecast by Regions (2019-2027)
Figure North America Generic Medicine Market Forecast (2019-2027)
Figure United States Generic Medicine Market Forecast (2019-2027)
Figure Canada Generic Medicine Market Forecast (2019-2027)
Figure Mexico Generic Medicine Market Forecast (2019-2027)
Figure Europe Generic Medicine Market Forecast (2019-2027)
Figure Germany Generic Medicine Market Forecast (2019-2027)
Figure France Generic Medicine Market Forecast (2019-2027)
Figure UK Generic Medicine Market Forecast (2019-2027)
Figure Russia Generic Medicine Market Forecast (2019-2027)
Figure Italy Generic Medicine Market Forecast (2019-2027)
Figure Rest of Europe Generic Medicine Market Forecast (2019-2027)
Figure Asia-Pacific Generic Medicine Market Forecast (2019-2027)
Figure China Generic Medicine Market Forecast (2019-2027)
Figure Japan Generic Medicine Market Forecast (2019-2027)
Figure Korea Generic Medicine Market Forecast (2019-2027)
Figure India Generic Medicine Market Forecast (2019-2027)
Figure Southeast Asia Generic Medicine Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Generic Medicine Market Forecast (2019-2027)
Figure South America Generic Medicine Market Forecast (2019-2027)
Figure Brazil Generic Medicine Market Forecast (2019-2027)
Figure Argentina Generic Medicine Market Forecast (2019-2027)
Figure Columbia Generic Medicine Market Forecast (2019-2027)
Figure Rest of South America Generic Medicine Market Forecast (2019-2027)
Figure Middle East and Africa Generic Medicine Market Forecast (2019-2027)
Figure Saudi Arabia Generic Medicine Market Forecast (2019-2027)
Figure United Arab Emirates Generic Medicine Market Forecast (2019-2027)
Figure Egypt Generic Medicine Market Forecast (2019-2027)
Figure Nigeria Generic Medicine Market Forecast (2019-2027)
Figure South Africa Generic Medicine Market Forecast (2019-2027)
Figure Turkey Generic Medicine Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Generic Medicine Market Forecast (2019-2027)
Figure Global Generic Medicine Forecast by Product Type (2019-2027)
Figure Global Generic Medicine Market Share Forecast by Product Type (2019-2027)
Figure Global Generic Medicine Forecast by Product Type (2019-2027)
Figure Global Generic Medicine Forecast by Applications (2019-2027)
Figure Global Generic Medicine Market Share Forecast by Applications (2019-2027)
Figure Global Generic Medicine Forecast by Applications (2019-2027)
Figure Global Generic Medicine Forecast by Distribution Channel (2019-2027)
Figure Global Generic Medicine Market Share Forecast by Distribution Channel (2019-2027)
Figure Global Generic Medicine Forecast by Distribution Channel (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|